Yin, X., Latif, R., Bahn, R
Other studies looked at patients with cancers such as breast, lung, colorectal, and liver cancer
This lag between medical consensus and insurance policy means thousands of patients who could benefit from GLP-1 therapy must find alternative access pathways, including direct-pay options through licensed compounding pharmacies
(I wrote about Medicare approval and these drugs in detail previously.) The impediment to the weight loss industrys ultimate goal of Medicare coverage is that after the Fen-Phen disaster harmed and killed higher-weight people, Medicare stopped covering weight loss drugs
10.1016/j.abb.2010.11.009 Songisepp E, Kals J, Kullisaar T, Mndar R, Hutt P, Zilmer M, Mikelsaar M: Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers
Evid Based Complement Altern Med 2021(1):6613140 Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F (2020) Global burden of 5 major types of gastrointestinal cancer
